Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Barbara A. Belli is active.

Publication


Featured researches published by Barbara A. Belli.


Journal of Virology | 2000

Infection of Human Dendritic Cells by a Sindbis Virus Replicon Vector Is Determined by a Single Amino Acid Substitution in the E2 Glycoprotein

Jason P. Gardner; Ilya Frolov; Silvia Perri; Yaying Ji; Mary Lee MacKichan; Jan zur Megede; Minchao Chen; Barbara A. Belli; David A. Driver; Scott Sherrill; Catherine Greer; Gillis Otten; Susan W. Barnett; Margaret A. Liu; Thomas W. Dubensky; John M. Polo

ABSTRACT The ability to target antigen-presenting cells with vectors encoding desired antigens holds the promise of potent prophylactic and therapeutic vaccines for infectious diseases and cancer. Toward this goal, we derived variants of the prototype alphavirus, Sindbis virus (SIN), with differential abilities to infect human dendritic cells. Cloning and sequencing of the SIN variant genomes revealed that the genetic determinant for human dendritic cell (DC) tropism mapped to a single amino acid substitution at residue 160 of the envelope glycoprotein E2. Packaging of SIN replicon vectors with the E2 glycoprotein from a DC-tropic variant conferred a similar ability to efficiently infect immature human DC, whereupon those DC were observed to undergo rapid activation and maturation. The SIN replicon particles infected skin-resident mouse DC in vivo, which subsequently migrated to the draining lymph nodes and upregulated cell surface expression of major histocompatibility complex and costimulatory molecules. Furthermore, SIN replicon particles encoding human immunodeficiency virus type 1 p55Gag elicited robust Gag-specific T-cell responses in vitro and in vivo, demonstrating that infected DC maintained their ability to process and present replicon-encoded antigen. Interestingly, human and mouse DC were differentially infected by selected SIN variants, suggesting differences in receptor expression between human and murine DC. Taken together, these data illustrate the tremendous potential of using a directed approach in generating alphavirus vaccine vectors that target and activate antigen-presenting cells, resulting in robust antigen-specific immune responses.


Journal of Virology | 2000

Replicon vectors derived from Sindbis virus and Semliki forest virus that establish persistent replication in host cells.

Silvia Perri; David A. Driver; Jason P. Gardner; Scott Sherrill; Barbara A. Belli; Thomas W. Dubensky; John M. Polo

ABSTRACT Alphavirus replicon vectors are well suited for applications where transient, high-level expression of a heterologous gene is required. Replicon vector expression in cells leads to inhibition of host macromolecular synthesis, culminating in eventual cell death by an apoptotic mechanism. For many applications, including gene expression studies in cultured cells, a longer duration of transgene expression without resulting cytopathic effects is useful. Recently, noncytopathic Sindbis virus (SIN) variants were isolated in BHK cells, and the mutations responsible were mapped to the protease domain of nonstructural protein 2 (nsP2). We report here the isolation of additional variants of both SIN and Semliki Forest virus (SFV) replicons encoding the neomycin resistance gene that can establish persistent replication in BHK cells. The SIN and SFV variant replicons resulted from previously undescribed mutations within one of three discrete regions of the nsP2 gene. Differences among the panel of variants were observed in processing of the nonstructural polyprotein and in the ratios of subgenomic to genomic RNAs. Importantly, high-level expression of a heterologous gene was retained with most replicons. Finally, in contrast to previous studies, efficient packaging was obtained with several of the variant replicons. This work expands the utility of noncytopathic replicons and the understanding of how alphavirus replicons establish persistent replication in cultured cells.


Journal of Virology | 1996

Sindbis virus DNA-based expression vectors: utility for in vitro and in vivo gene transfer.

Thomas W. Dubensky; David A. Driver; John M. Polo; Barbara A. Belli; Emi M. Latham; Carlos E. Ibanez; Sunil Chada; Duane Brumm; Theresa A. Banks; Steven J. Mento; Douglas J. Jolly; Stephen M. W. Chang


Journal of Virology | 1998

DNA Immunization against Herpes Simplex Virus: Enhanced Efficacy Using a Sindbis Virus-Based Vector

Mangala J. Hariharan; David A. Driver; Kay Townsend; Duane Brumm; John M. Polo; Barbara A. Belli; Donald J. Catton; David Chi-Tang Hsu; Denise Mittelstaedt; James E. McCormack; Linda Karavodin; Thomas W. Dubensky; Stephen M. W. Chang; Theresa Banks


Proceedings of the National Academy of Sciences of the United States of America | 1999

Stable alphavirus packaging cell lines for Sindbis virus- and Semliki Forest virus-derived vectors

John M. Polo; Barbara A. Belli; David A. Driver; Ilya Frolov; Scott Sherrill; Mangala J. Hariharan; Kay Townsend; Silvia Perri; Steven J. Mento; Douglas J. Jolly; Stephen M. W. Chang; Sondra Schlesinger; Thomas W. Dubensky


Archive | 1998

Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis

Thomas W. Dubensky; John M. Polo; Barbara A. Belli; Sondra Schlesinger; Sergey A. Dryga; Ilya Frolov


Archive | 1997

Alphaviral vector with reduced inhibition of cellular macromolecular synthesis

Thomas W. Dubensky; John M. Polo; Barbara A. Belli; Sondra Schlesinger; Sergey A. Dryga; Ilya Frolov


Annals of the New York Academy of Sciences | 1995

Layered Amplification of Gene Expression with a DNA Gene Delivery System

David A. Driver; Emi M. Latham; John M. Polo; Barbara A. Belli; Theresa A. Banks; Sunil Chada; Duane Brumm; Stephen M. W. Chang; Steven J. Mento; Douglas J. Jolly; Thomas W. Dubensky


Archive | 2000

Verbesserung der immunantwort als anwendung in impfstoff und gentherapie Improve the immune response as an application in vaccine and gene therapy

Barbara A. Belli; Thomas W. Piedmont Dubensky; Timothy Moraga Fong; Silvia Perri; John Polo


Archive | 2000

Improve the immune response as an application in vaccine and gene therapy

Barbara A. Belli; Thomas W. Piedmont Dubensky; Timothy Moraga Fong; Silvia Perri; John Polo

Collaboration


Dive into the Barbara A. Belli's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ilya Frolov

Washington University in St. Louis

View shared research outputs
Top Co-Authors

Avatar

Sondra Schlesinger

Washington University in St. Louis

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Sergey A. Dryga

Washington University in St. Louis

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge